|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7012 | |
| C12N 15/09 |
| (11) | Patento numeris | 3113781 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15758766.8 |
| Europos patento paraiškos padavimo data | 2015-03-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-01-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/018859 |
| Data | 2015-03-05 |
| (87) | Numeris | WO 2015/134696 |
| Data | 2015-09-11 |
| (30) | Numeris | Data | Šalis |
| 201461948421 P | 2014-03-05 | US | |
| 201562114313 P | 2015-02-10 | US |
| (72) |
JUNGLES, Steven, US
MORRIS, Gabrielle, US
GRUBB, Jeff, US
VELLARD, Michael, US
KAKKIS, Emil D., US
|
| (73) |
Ultragenyx Pharmaceutical Inc.,
60 Leveroni Court, Novato, CA 94949,
US
|
| (54) | SIALYLATED GLYCOPROTEIN COMPOSITIONS AND USES THEREOF |
| SIALYLATED GLYCOPROTEIN COMPOSITIONS AND USES THEREOF |